A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues

被引:5
|
作者
Caballero, Julio [1 ]
Fernandez, Michael [2 ,3 ]
Gonzalez-Nilo, Fernando D. [1 ]
机构
[1] Univ Talca, Ctr Bioinformat & Simulac Mol, Casilla 721, Talca, Chile
[2] Univ Matanzas, Ctr Biotechnol Studies, Mol Modeling Grp, Matanzas, Cuba
[3] Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka 8208502, Japan
关键词
adenosine kinase inhibitors; in silico drug design; quantitative structure-activity relationships; CoMSIA;
D O I
10.1016/j.bmc.2008.03.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structural requirements of pyrrolo [2,3-d] pyrimidine nucleoside (PPN) analogues as adenosine kinase (AK) inhibitors were in silico studied by using CoMSIA method. All models were trained with 32 compounds, after which they were evaluated for predictive ability with additional 5 compounds. Quantitative information on structure-activity trends is provided for further rational development and direction of selective synthesis. The best CoMSIA model included hydrophobic, H-bond donor and H-bond acceptor fields and had a good predictive quality according to internal validation criteria. In addition, this model predicted adequately the compounds contained in the test set. The analysis of the model gives a comprehensive qualitative and quantitative description of the molecular features at C4 and C5 positions of the pyrrolo [2,3-d] pyrimidine scaffold and C5-position of the beta-D-ribofuranose of PPN analogues, relevant for a high AK inhibitory activity. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5103 / 5108
页数:6
相关论文
共 50 条
  • [41] 4-Chloro-1H-pyrrolo[2,3-d] pyrimidine
    Dong, Su-Lan
    Cheng, Xiaochun
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2666 - +
  • [42] Synthesis of benzimidazole and pyrrolo[2,3-d]pyrimidine analogues of 'iso-2',3'-dideoxyadenosine' (iso-ddA)
    Navarre, N
    Preston, PN
    Tsytovich, AV
    Wightman, RH
    JOURNAL OF CHEMICAL RESEARCH-S, 1996, (10): : 444 - 445
  • [43] PYRROLOPYRIMIDINE NUCLEOSIDES .4. SYNTHESIS OF CERTAIN 4,5-DISUBSTITUTED-7-(BETA-D-RIBOFURANOSYL)PYRROLO[2,3-D]PYRIMIDINES RELATED TO PYRROLO[2,3-D]PYRIMIDINE NUCLEOSIDE ANTIBIOTICS
    HINSHAW, BC
    GERSTER, JF
    ROBINS, RK
    TOWNSEND, LB
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 1969, 6 (02) : 215 - &
  • [44] Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity
    Alotaibi, AbdulAziz A.
    Asiri, Hanadi H.
    Rahman, A. F. M. Motiur
    Alanazi, Mohammed M.
    JOURNAL OF SAUDI CHEMICAL SOCIETY, 2023, 27 (05)
  • [45] 2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases' inhibition by substituted pyrido[2,3-d]pyrimidine derivatives
    Caballero, Julio
    Fernandez, Michael
    Saavedra, Mario
    Gonzalez-Niloa, Fernando D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (02) : 810 - 821
  • [46] SYNTHESIS OF PYRROL[2,3-d]PYRIMIDINE ANALOGUES: "PYRIDINE RING" ANALOGUES OF PEMETREXED
    Xu, Yun
    Yu, Mingfeng
    Long, Yan
    Wu, Han
    Mao, Zhenmin
    HETEROCYCLES, 2009, 78 (09) : 2353 - 2360
  • [47] 5′-Norcarbocyclic analogues of furano[2,3-d]pyrimidine nucleosides
    Matyugina, Elena S.
    Logashenko, Evgeniya B.
    Zenkova, Marina A.
    Kochetkov, Sergey N.
    Khandazhinskaya, Anastasia L.
    HETEROCYCLIC COMMUNICATIONS, 2015, 21 (05) : 259 - 262
  • [48] PREPARATION OF CYCLOPROPA[4,5]PYRIDO[2,3-D]-PYRIMIDINE AND PYRROLO[2,3-D]-PYRIMIDINE DERIVATIVES USING INTRAMOLECULAR CARBENE REACTIONS
    NOGUCHI, M
    FUJIMOTO, N
    NAGASHIMA, M
    KAJIGAESHI, S
    HETEROCYCLES, 1989, 29 (10) : 1993 - 1996
  • [49] SYNTHESIS OF 7-GLYCOPYRANOSYL-5-OXO-PYRROLO[2,3-D]PYRIMIDINE AND 4-GLYCOPYRANOSYLAMINO-FURO[2,3-D]PYRIMIDINE DERIVATIVES
    NOGUERAS, M
    QUIJANO, ML
    SANCHEZ, A
    MELGAREJO, M
    NUCLEOSIDES & NUCLEOTIDES, 1987, 6 (1-2): : 373 - 374
  • [50] Pyrrolo[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines as conformationally restricted analogues of the antibacterial agent trimethoprim
    Kuyper, LF
    Garvey, JM
    Baccanari, DP
    Champness, JN
    Stammers, DK
    Beddell, CR
    BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (04) : 593 - 602